Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
Andrea Santamato Physical Medicine and Rehabilitation Section, “OORR Hospital,” University of Foggia, Foggia, Italy Abstract: Spasticity is a common disabling symptom for several neurological conditions. Botulinum toxin type A injection represents the gold standard treatment fo...
Saved in:
Main Author: | Santamato A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/a46c4cff9f314e0cb8b6987eb9ab881e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: A review of the science, the clinical data, and patient satisfaction
by: Koenraad De Boulle, et al.
Published: (2010) -
Muscle Selection and Dosing in a Phase 3, Pivotal Study of AbobotulinumtoxinA Injection in Upper Limb Muscles in Children With Cerebral Palsy
by: Joyce Oleszek, et al.
Published: (2021) -
Localization of the Centers of Intramuscular Nerve Dense Regions of the Rotator Cuff Muscles: A Guide for Botulinum Toxin A Injection for Spasticity Accompanied by Shoulder Pain
by: Luo,Huaixiang, et al.
Published: (2020) -
AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
by: Mark F. Lew, et al.
Published: (2021) -
Caregiver burden, productivity loss, and indirect costs associated with caring for patients with poststroke spasticity
by: Ganapathy V, et al.
Published: (2015)